CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- 4 Open-market sale Chief Legal Officer sold 14,212 shares at $24.50 ($348,194)
- 4 Option exercise Chief Medical Officer acquired 40,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,176,470 shares at $17.00 ($19,999,990)
- 4/A Shares withheld for taxes Chief Financial Officer gave up 2,031 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Operating Officer gave up 3,048 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Legal Officer gave up 1,675 shares (to pay taxes)
- 4/A Shares withheld for taxes President and CEO gave up 7,408 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,724 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,091 shares (to pay taxes)
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4 Shares withheld for taxes Chief Operating Officer gave up 3,138 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 7,627 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
Page 1 of 14 · 264 filings